Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Porter

Showing results (511-520 of 632) with videos related to

Pageof 64
Sort By:
Contemporary Clinical Trials Communications|April 17, 2019
Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristicsChad K Porter, Mark S Riddle, Ramiro L Gutierrez, et al.
Nano Letters|March 28, 2026
Analysis of Nanosensor-Reported Waveforms for Plant WoundingCody L Ritt, Yile Jiang, Gabriel Sánchez-Velázquez, et al.
Plos One|March 29, 2018
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity scoreChad K Porter, Amanda Lynen, Mark S Riddle, et al.
Clinical and Vaccine Immunology : CVI|June 27, 2008
Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192GJoyce A Lapa, Stephanie A Sincock, Madhumita Ananthakrishnan, et al.
Vaccine|September 4, 2023
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteersChristopher Duplessis, Kristen A Clarkson, K Ross Turbyfill, et al.
Journal of Clinical Microbiology|June 18, 2010
Caught in the act: in vivo development of macrolide resistance to Campylobacter jejuni infectionJ C Lindow, F Poly, D R Tribble, et al.
Infection and Immunity|September 24, 2008
Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studiesFrédéric Poly, Timothy D Read, Yu-Han Chen, et al.
Plos Neglected Tropical Diseases|October 3, 2025
Intestinal inflammation induced by heat-labile toxin-producing enterotoxigenic E: Coli infection and impact on immune responses in an experimental human challenge modelXueyan Zhang, Jessica Brubaker, Kawsar R Talaat, et al.
Microorganisms|February 24, 2024
Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic <i>Escherichia coli</i> CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic <i>E. coli</i> H10407 in Healthy Adult VolunteersRamiro L Gutiérrez, Chad K Porter, Clayton Harro, et al.
Advances in Nutrition (Bethesda, Md.)|February 23, 2023
Orally Ingested Probiotic, Prebiotic, and Synbiotic Interventions as Countermeasures for Gastrointestinal Tract Infections in Nonelderly Adults: A Systematic Review and Meta-AnalysisHeather S Fagnant, Sandra D Isidean, Lydia Wilson, et al.
Pageof 64

Showing results (511-520 of 632) with videos related to

Sort By:
Pageof 64
Contemporary Clinical Trials Communications|April 17, 2019
Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristicsChad K Porter, Mark S Riddle, Ramiro L Gutierrez, et al.
Nano Letters|March 28, 2026
Analysis of Nanosensor-Reported Waveforms for Plant WoundingCody L Ritt, Yile Jiang, Gabriel Sánchez-Velázquez, et al.
Plos One|March 29, 2018
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity scoreChad K Porter, Amanda Lynen, Mark S Riddle, et al.
Clinical and Vaccine Immunology : CVI|June 27, 2008
Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192GJoyce A Lapa, Stephanie A Sincock, Madhumita Ananthakrishnan, et al.
Vaccine|September 4, 2023
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteersChristopher Duplessis, Kristen A Clarkson, K Ross Turbyfill, et al.
Journal of Clinical Microbiology|June 18, 2010
Caught in the act: in vivo development of macrolide resistance to Campylobacter jejuni infectionJ C Lindow, F Poly, D R Tribble, et al.
Infection and Immunity|September 24, 2008
Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studiesFrédéric Poly, Timothy D Read, Yu-Han Chen, et al.
Plos Neglected Tropical Diseases|October 3, 2025
Intestinal inflammation induced by heat-labile toxin-producing enterotoxigenic E: Coli infection and impact on immune responses in an experimental human challenge modelXueyan Zhang, Jessica Brubaker, Kawsar R Talaat, et al.
Microorganisms|February 24, 2024
Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic <i>Escherichia coli</i> CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic <i>E. coli</i> H10407 in Healthy Adult VolunteersRamiro L Gutiérrez, Chad K Porter, Clayton Harro, et al.
Advances in Nutrition (Bethesda, Md.)|February 23, 2023
Orally Ingested Probiotic, Prebiotic, and Synbiotic Interventions as Countermeasures for Gastrointestinal Tract Infections in Nonelderly Adults: A Systematic Review and Meta-AnalysisHeather S Fagnant, Sandra D Isidean, Lydia Wilson, et al.
Pageof 64